Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-256011
Filing Date
2026-06-03
Accepted
2026-06-03 19:20:22
Documents
1
Period of Report
2026-06-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14311
  Complete submission text file 0001193125-26-256011.txt   15706
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
Mokari Atabak (Reporting) CIK: 0001678419 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 261062717